yl23455永利官网

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR2400082766】Implementation of an integrated Self-Care Health Service Ecosystem

    基本信息
    登记号

    ChiCTR2400082766

    试验状态

    尚未开始

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2024-04-07

    临床申请受理号

    /

    靶点

    /

    适应症

    None

    试验通俗题目

    Implementation of an integrated Self-Care Health Service Ecosystem

    试验专业题目

    Development and implementation of an integrated Self-Care Health Service Ecosystem

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    This seed project will serve as the first phase of the development and implementation of the self-care health service ecosystem. During the first phase, we will mainly focus on the conceptualization and planning, and creation of prototype of SHE. Thus, this project aims to: 1) To identify the core features of the app and prioritize them to create the Minimum Viable Product; 2) To create wireframes and prototype to visualize the app’s layout, user flow, and interactions (prototype creation); 3) To understand users’ experience on the use of HPV self-sampling and Dried Blood Spot (DBS) in general population (experience test); 4) To validate the risk algorithms for disease prevention and health problem alert; and 5) To explore the health information that the users are in need and can be used to train the chatbot (needs exploration).

    试验分类
    试验类型

    横断面

    试验分期

    其它

    随机化

    N/A

    盲法

    None

    试验项目经费来源

    Innovation and Technology Fund

    试验范围

    /

    目标入组人数

    192

    实际入组人数

    /

    第一例入组时间

    2023-12-01

    试验终止时间

    2025-12-01

    是否属于一致性

    /

    入选标准

    1) HK resident; 2) Aged 18 or above; and 3) Able to read, understand and speaking Cantonese or English.；

    排除标准

    1) Current pregnancy at the time of recruitment; 2) Had total hysterectomy; 3) Have been diagnosed with an immunocompromised condition (e.g. Systemic Lupus Erythematosus, or illness with steroid-dependent); or 4) Have been diagnosed with any gynecologic cancers (e.g. cervical, ovarian, vaginal, uterine, vulvar, or breast cancer).；

    研究者信息
    研究负责人姓名
    试验机构

    The Chinese University of Hong Kong

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    The Chinese University of Hong Kong的其他临床试验

    更多

    The Chinese University of Hong Kong的其他临床试验

    更多

    最新临床资讯

    yl23455永利官网企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品